Militello John 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 20, 2026
Research Summary
AI-generated summary of this filing
Rocket Pharmaceuticals VP Finance John Militello Sells Shares
What Happened John Militello, Vice President of Finance, Treasurer and Principal Accounting Officer at Rocket Pharmaceuticals (RCKT), sold 1,157 shares of common stock on 2026-02-18 in an open-market/private sale. The shares were sold at $3.34 per share for total proceeds of $3,862. The filing indicates the sale was made to satisfy tax withholding obligations related to vested Restricted Stock Units (RSUs).
Key Details
- Transaction date: 2026-02-18; filing date: 2026-02-20 (timely filing).
- Transaction type/code: Sale (S).
- Shares sold: 1,157 at $3.34 per share; total value $3,862.
- Reason: Sold to pay tax withholding on RSU vesting (footnote F2).
- Holdings note: Reported holdings include RSUs that convert one-for-one to common stock (footnote F1).
- Shares owned after transaction: Not specified in the provided excerpt.
Context
- This was a withholding-related sale tied to RSU vesting, a common and routine reason for insider sales that does not necessarily signal a change in insider sentiment.
- No option exercises, gifts, or 10% owner transfers are indicated in this filing.
Insider Transaction Report
Form 4
Militello John
See Remarks
Transactions
- Sale
Common Stock
[F1][F2]2026-02-18$3.34/sh−1,157$3,862→ 91,019 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Signature
/s/ Martin Wilson, as attorney-in-fact for John Militello|2026-02-20